| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 12, 2021 | MTD Mettler Toledo International Inc/ | Keller Gerry64 | Head Of Process Analytics | Sell | 124 | $1,513.88 | $187,721.12 | -56.6% | +1.8% | -10.1% | |
| Aug 11, 2021 | RDNT Radnet, Inc. | Swartz David L | Director | Buy | 4,519 | $33.47 | $151,271.27 | New | -4.7% | -34.1% | |
| Aug 10, 2021 | GH Guardant Health, Inc. | Meresman Stanley J75 | Director | Sell | 4,934 | $114.31 | $564,005.54 | -54.9% | +5.1% | -49.5% | |
| Aug 10, 2021 | MTD Mettler Toledo International Inc/ | Spoerry Robert F70 | Director | Sell | 1,000 | $1,530.00 | $1,530,000.00 | -13.7% | +1.8% | -11.1% | |
| Aug 9, 2021 | BIO Bio-Rad Laboratories, Inc. | Crowley Michael60 | EVP, Gbl Commercial Operations | Sell | 3,000 | $754.93 | $2,264,795.60 | -27.9% | -3.2% | -31.4% | |
| Aug 9, 2021 | OPK Opko Health, Inc. | Hsiao Jane Ph D65 | Vice Chairman &CTO | Buy | 10 | $3.73 | $37.30 | - | +11.5% | -32.9% | |
| Aug 9, 2021 | MTD Mettler Toledo International Inc/ | Filliol Oliver A71 | Director | Sell | 7,500 | $1,521.04 | $11,407,775.68 | -2.8% | +1.3% | -13.7% | |
| Aug 9, 2021 | CRL Charles River Laboratories International, Inc. | Smith David Ross63 | Corporate Executive VP &CFO | Sell | 1,750 | $407.40 | $712,954.21 | -5.5% | -8.7% | -47.6% | |
| Aug 9, 2021 | TMO Thermo Fisher Scientific Inc. | Holmes Joseph R. | VP &Chief Accounting Officer | Sell | 759 | $542.75 | $411,948.23 | -29.7% | +15.4% | +7.6% | |
| Aug 6, 2021 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman, President And CEO | Sell | 10,000 | $401.79 | $4,017,867.40 | -1.0% | -7.1% | -45.3% | |
| Aug 6, 2021 | CRL Charles River Laboratories International, Inc. | Kochevar Deborah Turner | Director | Sell | 3,526 | $406.43 | $1,433,071.03 | -14.4% | -7.1% | -45.3% | |
| Aug 6, 2021 | MTD Mettler Toledo International Inc/ | Spoerry Robert F70 | Director | Sell | 1,000 | $1,530.00 | $1,530,000.00 | -13.7% | -2.5% | -11.4% | |
| Aug 6, 2021 | CRL Charles River Laboratories International, Inc. | Laplume Joseph W66 | EVP, Corp Strategy &Develop | Sell | 3,700 | $402.21 | $1,488,175.19 | -8.9% | -7.1% | -45.3% | |
| Aug 6, 2021 | PSNL Personalis, Inc. | Chen Richard70 | Chief Scientific Officer | Sell | 4,436 | $21.22 | $94,131.92 | -5.1% | +1.5% | -76.3% | |
| Aug 6, 2021 | CRL Charles River Laboratories International, Inc. | Barbo William D66 | Corporate Executive VP &CCO | Sell | 12,387 | $402.82 | $4,989,751.58 | -15.8% | -7.1% | -45.3% | |
| Aug 5, 2021 | MYGN Myriad Genetics Inc | Lanchbury Jerry S81 | Chief Scientific Officer | Sell | 28,225 | $35.57 | $1,004,008.41 | -10.8% | -17.5% | -22.6% | |
| Aug 5, 2021 | A Agilent Technologies, Inc. | Grau Dominique70 | Senior Vice President | Sell | 9,033 | $155.00 | $1,400,115.00 | -10.0% | +2.2% | -13.3% | |
| Aug 5, 2021 | WAT Waters Corp /de/ | Salice Thomas P65 | Director | Sell | 8,500 | $395.00 | $3,357,500.00 | -8.8% | -12.5% | -15.0% | |
| Aug 5, 2021 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | CEO | Sell | 556 | $180.04 | $100,102.24 | - | +24.5% | -8.0% | |
| Aug 5, 2021 | MTD Mettler Toledo International Inc/ | Chu Wah-Hui63 | Director | Sell | 45 | $1,528.00 | $68,760.00 | -1.8% | -3.7% | -11.8% | |
| Aug 5, 2021 | MTD Mettler Toledo International Inc/ | Filliol Oliver A71 | Director | Sell | 5,000 | $1,516.99 | $7,584,956.36 | -1.8% | -3.7% | -11.8% | |
| Aug 5, 2021 | CDNA Caredx, Inc. | Maag Peter83 | Executive Chair | Sell | 10,000 | $83.13 | $831,312.94 | -1.4% | -42.4% | -68.7% | |
| Aug 5, 2021 | MYGN Myriad Genetics Inc | Phanstiel S. Louise62 | Director | Sell | 47,881 | $35.04 | $1,677,740.66 | -43.7% | -17.5% | -22.6% | |
| Aug 5, 2021 | XGN Exagen Inc. | Tullis James L L73 | Director | Sell | 6,800 | $10.72 | $72,862.68 | -0.4% | +14.3% | -39.6% | |
| Aug 5, 2021 | MEDP Medpace Holdings, Inc. | Medpace Investors, LLC69 | 10% Owner | Sell | 556 | $180.04 | $100,102.24 | - | +24.5% | -8.0% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.